EXCLUSIVE: Avalon GloboCare Drops Old Identity, Rebrands as Change Agents to Chase AI Boom - Avalon Globo

Avalon GloboCare is rebranding as Change Agents and will start trading on Nasdaq Capital Market under ticker CHGA on July 22, 2026, with no change to shareholder ownership, according to the company. The shift follows its acquisition of RPM Interactive and focuses on agentic AI SaaS platforms Beacon and Catch-Up, plus distribution of KetoAir. Shares were down 1.43% to $0.2821 premarket, per Benzinga Pro.

Original reporting
Published Jul 21, 2026, 4:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
EXCLUSIVE: Avalon GloboCare Drops Old Identity, Rebrands as Change Agents to Chase AI Boom - Avalon Globo — source image
Decision brief

The 30-second read

Med
01

Why it matters

The key actionable event is the Nasdaq ticker change to CHGA effective July 22, 2026. The article also outlines an AI product roadmap (Beacon expected late Q3 2026; Catch-Up in Phase 2) and mentions AWS partner development for Catch-Up.

02

Market read

Traders may need to update watchlists and order routing for the new CHGA ticker, while longer-term positioning hinges on the stated AI platform milestones.

03

What to watch

No revenue, cash, or funding details are provided, and the KetoAir medical device business is mentioned without performance metrics, limiting conviction on near-term valuation impact.

Relevance 6/10Novelty 6/10Timing: Ahead of the July 22, 2026 Nasdaq ticker change for CHGA.

Background

Avalon GloboCare rebranded as Change Agents after acquiring RPM Interactive and shifting from diversified tech to agentic AI SaaS.

Market effects

Rebranding toward agentic AI SaaS may attract AI-themed small-cap flows, but the article provides no measurable traction metrics.

US microcap/Nasdaq trading mechanics may see short-term attention around the identifier change.

Limited, as the disclosure is company-specific and US-market listing related.

Counterpoint

The AI pivot and platform roadmap may be largely narrative until Beacon and Catch-Up reach commercialization; the ticker change itself may not improve fundamentals.

Key entities

  • CHGA

    New Nasdaq Capital Market trading symbol for Avalon GloboCare starting July 22, 2026.

  • RPM Interactive

    Acquisition referenced as the backdrop for the rebrand and business shift.

  • Beacon

    AI Generative Engine Optimization platform expected to launch in late third quarter 2026.

  • Catch-Up

    Autonomous AI-powered content creation platform for podcasters and social media creators, in Phase 2 development.

  • Caylent

    AWS Premier Tier Services Partner referenced as involved in developing Catch-Up.

Related articles

$TSEMMedAI 8/10

Tower Semiconductor plans $4bn Japan chip hub – report

Tower Semiconductor plans a $4bn investment in Japan to build its largest optical communications semiconductor hub, aiming to boost production capacity 40x by 2029. The move targets silicon photonics demand, with potential collaboration with NTT. The company holds over 80% of the contract manufacturing market for optical communications semiconductors used in servers.

$SBUXMed

Starbucks closing 250 more stores

Starbucks plans to close 250 underperforming stores in North America, incurring $300M in restructuring costs. The closures represent 1% of its North American locations. The company also reduced its new store openings target. Starbucks is retrofitting 1,500 stores by September 30. Specific Canadian closures and job impacts were not disclosed.

$HSTMed

This Undervalued Cash Producer Will Pay Six Dividends in 2026

Host Hotels (HST) pays dividends quarterly with a variable year-end supplement, totaling at least $0.90 per share annually for a 4% yield. The company owns 74 luxury resorts, with strong occupancy and high average daily rates. Host generated $241 million in GAAP profit last quarter, with FFO doubling that figure. It plans $600 million in capital expenditures and is engaged in portfolio recycling, selling high and buying low. The company recently made a special dividend payment from asset sales.

$MRNAHighAI 8/10

Bernstein reiterates Moderna stock rating on mRNA platform progress

Bernstein reiterated a Market Perform rating and $45 price target for Moderna (MRNA), citing progress in its mRNA platform. The stock trades near its 52-week high at $194.82, with mixed analyst opinions on its valuation. Moderna announced a $2 billion convertible notes offering. Analysts have varying views, with UBS maintaining Neutral, Rothschild Redburn downgrading to Sell, and Argus upgrading to Buy.